HDAC1 and familial dilated cardiomyopathy: β‐Hydroxybutyrate can enhance the antioxidant function of cardiomyocytes and antagonise the microvascular hyperpermeability associated with DCM by inhibiting HDAC1 and HDAC3 while promoting the expression of Trx1 and claudin‐5 [130, 131].